Suppr超能文献

传染性前葡萄膜炎治疗算法网络(TITAN)报告 1-单纯疱疹病毒和水痘带状疱疹病毒前葡萄膜炎管理的全球当前实践模式。

The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis.

机构信息

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.

Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia.

出版信息

Eye (Lond). 2024 Jan;38(1):61-67. doi: 10.1038/s41433-023-02630-9. Epub 2023 Jul 7.

Abstract

AIMS

To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide.

METHODS

A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used.

RESULTS

Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints.

CONCLUSIONS

Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts.

摘要

目的

介绍当前的专家实践模式,并为全球葡萄膜炎专家制定单纯疱疹病毒(HSV)和水痘带状疱疹病毒(VZV)相关性葡萄膜炎(AU)的管理共识。

方法

采用两轮在线改良 Delphi 调查,并对研究团队进行了掩蔽。从 21 个国家的 76 名国际葡萄膜炎专家中收集了应答。确定了 HSV 和 VZV AU 的诊断和治疗的当前实践。一个工作组(感染性葡萄膜炎治疗算法网络[TITAN])将数据制定成共识指南。使用 Likert 量表时,共识定义为对特定问题的特定应答达到≥75%的一致性或 IQR≤1。

结果

从共识意见来看,单侧性、眼内压(IOP)升高、角膜知觉减退和弥漫性或扇形虹膜萎缩是 HSV 或 VZV AU 的特异性表现。扇形虹膜萎缩是 HSV AU 的特征。治疗开始的时间差异很大,但由于剂量更简单,大多数专家更喜欢伐昔洛韦。如果需要,应使用局部皮质类固醇和β受体阻滞剂。炎症消退和 IOP 正常化是临床终点。

结论

在 HSV 和 VZV AU 的诊断、初始治疗选择和治疗终点方面达成了共识。治疗持续时间和复发管理在专家之间存在差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验